Evaluating a One-Year Version of the Parent-Child Assistance Program
for Alcohol Use Disorder
2 locations incl. Enid
Sponsor: University of Oklahoma
Sex: All·Age: 18+
Code: NCT06163651·Recruiting
Alcohol use disorder Clinical Trials in Oklahoma City, OK
As of June 2026, 2 paid clinical trials are recruiting for Alcohol use disorder in Oklahoma City, Oklahoma. Alcohol use disorder trials evaluate GLP-1 agonists, novel pharmacotherapies, and digital therapeutics as adjuncts to behavioral treatment. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Oklahoma City
Filter results
Filter results
2 clinical trials for Alcohol use disorder
·Clear filters·↓ Download CSVThe Oklahoma Parent-Child Assistance Program
for Substance Use Disorders
2 locations incl. Oklahoma City
Sponsor: University of Oklahoma
Sex: Female·Age: 18+
Code: NCT05534568·Recruiting
About research studies in Oklahoma City
Oklahoma City has approximately 644 recruiting research studies across a wide range of therapeutic areas. Oklahoma hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Oklahoma City
Researchers run research studies in Oklahoma City, OK at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Oklahoma Health Sciences Center | Acute Myeloid Leukemia, Metastatic Malignant Solid Neoplasm, Stage IV Lung Cancer AJCC v8 | 207 |
| Mercy Hospital Oklahoma City | Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8 | 59 |
| University of Oklahoma | Endometrial Cancer, Colorectal Cancer, Ovarian Cancer | 28 |
| OU Health Stephenson Cancer Center | Ovarian Cancer, AML With Mutated NPM1, Acute Myeloid Leukemia | 20 |
| Stephenson Cancer Center | Breast Cancer, Cervical Cancer, Endometrial Cancer | 14 |
| Oklahoma Medical Research Foundation | Systemic Lupus Erythematosus, Aging, Multiple Sclerosis | 13 |
| The University of Oklahoma Health Sciences Center | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 12 |
| Oklahoma Heart Hospital | Mitral Regurgitation, Acute Decompensated Heart Failure, Aortic Stenosis | 10 |
| Hightower Clinical | Ulcerative Colitis, Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Cancer | 9 |
| TSET Health Promotion Research Center | CRC (Colorectal Cancer), CRC Screening, Smoking Cessation | 8 |
| Integris Southwest Medical Center | Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Advanced Esophageal Adenocarcinoma | 6 |
| University of Oklahoma Health Sciences | Acute Respiratory Distress Syndrome, Breast Cancer Survivor, Cancer Survivorship | 5 |
| GSK Investigational Site | Alzheimer's Disease, Asthma, Colonic Neoplasms | 4 |
| South Oklahoma Heart Research, LLC | Acute Myocardial Infarction (AMI), Cardiovascular Risk, Heart Failure | 4 |
| Integris Baptist Medical Center | Cardiovascular Diseases, Pulmonary Hypertension, Connective Tissue Diseases | 4 |
| Integris Cancer Institute of Oklahoma | Stage IIIB Lung Cancer AJCC v8, Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma | 4 |
| Oklahoma Cardiovascular Research Group | ADHF, Aortic Stenosis, Aortic Stenosis, Severe | 4 |
| Oklahoma Children's Hospital | Anesthesia, Asthma Attack, Asthma in Children | 4 |
| Oklahoma Proton Center | Breast Cancer, Breast Neoplasm, Breast Tumor | 4 |
| South Oklahoma Heart Research | Acute Coronary Syndrome, Heart Failure, Heart Failure With Mildly Reduced Ejection Fraction | 4 |
| Unity Clinical Research | Atopic Dermatitis, Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa | 4 |
| University of Oklahoma Health Campus | Brain Activity, Brain Aging, Cigar Smoking | 4 |
| University of Oklahoma Health Science Center | Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL), Autoimmune Diseases | 4 |
| Dean McGee Eye Institute | Choroidal Melanoma, Indeterminate Lesions, Ocular Melanoma | 3 |
| Lynn Health Science Institute | Migraine, Refractory or Unexplained Chronic Cough, Rheumatoid Arthritis | 3 |
Active & Upcoming Studies in Oklahoma City (2026)
Recruiting trials in Oklahoma City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (277 active studies)
- Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene · Phase 1, Phase 2 · National Cancer Institute (NCI)
- Improving Sleep, Fatigue, Activity & Quality of Life in Cancer Survivors Via a Transdiagnostic Intervention · University of Oklahoma
Cardiovascular (43 active studies)
- A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) · Phase 1 · Vasa Therapeutics
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Neurology & pain (27 active studies)
- The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms · phenox Inc.
- Skeletal Muscle Aging and Responsiveness in Aged People With MS · Oklahoma Medical Research Foundation
Mental health & behavior (25 active studies)
- Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention for Smoking Cessation · Phase 2 · University of Oklahoma
- Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT) · Bristol-Myers Squibb
Diabetes & metabolic (23 active studies)
- Impact of Chia Seeds on Human Breast Milk Composition · University of Oklahoma
- Disulfiram in Rheumatoid Arthritis · Phase 2 · University of Oklahoma
Pediatric (9 active studies)
- Supraglottic Airway for Resuscitation Trial · Children's Hospital of Philadelphia
- iAmHealthy Clinical Practice Guideline (CPG) · University of Kansas Medical Center
Vaccines (4 active studies)
- A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza · Phase 3 · Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children · Phase 3 · University of Alabama at Birmingham
Eye & vision (3 active studies)
- Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant · Phase 2, Phase 3 · Glaukos Corporation
- A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma · Phase 3 · AbbVie
HIV / STI (1 active study)
Common conditions studied in Oklahoma City
- Endometrial Cancer (16 active studies). Recruiting Endometrial Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Ovarian Cancer (14 active studies). Ovarian cancer research examines PARP inhibitors, maintenance therapies, and antibody-drug conjugates for recurrent and platinum-resistant disease.
- Acute Myeloid Leukemia (12 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Breast Cancer (11 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Major Depressive Disorder (10 active studies). Major depressive disorder research examines rapid-acting agents, augmentation strategies, and digital therapeutics for treatment-resistant cases.
- Malignant Solid Neoplasm (10 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Oklahoma City
- National Cancer Institute (NCI)
- University of Oklahoma
- NRG Oncology
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
Local regulations and guidelines
Clinical trials in Oklahoma are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Oklahoma research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Oklahoma City. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Oklahoma City
Hipa.ai aggregates every recruiting study in Oklahoma City from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Oklahoma City?
There are approximately 644 recruiting clinical trials in Oklahoma City, Oklahoma listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Oklahoma City pay participants?
Most recruiting trials in Oklahoma City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Oklahoma City?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Oklahoma City?
The most common conditions under active study in Oklahoma City include Endometrial Cancer (16), Ovarian Cancer (14), Acute Myeloid Leukemia (12), Breast Cancer (11), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Oklahoma City?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Oklahoma City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Oklahoma City?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Oklahoma City?
Recruiting research sites in Oklahoma City include University of Oklahoma Health Sciences Center, Mercy Hospital Oklahoma City, University of Oklahoma, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Oklahoma City right now?
The largest active categories in Oklahoma City are Cancer & tumors (277), Cardiovascular (43), Neurology & pain (27). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
Browse more clinical trials
Other cities in Oklahoma
Tulsa, OK(175)Edmond, OK(33)Lawton, OK(29)Norman, OK(27)Yukon, OK(8)Chickasha, OK(7)Bartlesville, OK(6)Enid, OK(3)Moore, OK(3)Ada, OK(2)Ardmore, OK(2)Elk City, OK(2)Muskogee, OK(2)Stillwater, OK(2)Tahlequah, OK(2)Altus, OK(1)Bethany, OK(1)Canton, OK(1)Duncan, OK(1)Durant, OK(1)Lindsay, OK(1)Multiple Locations, OK(1)